Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.5
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + pqbp1 MO + wbp11 MO
NF10.5 (RT-PCR)
|
|
|
|
Fig. S3 B
Yasuoka Y et al. (2014)
|
Xla Wt + tle1 + gsc + otx2 + ssbp3 + ldb1 + lhx1 mRNA
NF9 (RT-PCR)
|
|
|
|
fig.2.g
Mamidi A et al. (2012)
|
Xla Wt + mark2 MO
NF10.5 (in situ hybridization)
|
|
|
|
fig.7.b
Mamidi A et al. (2012)
|
Xla Wt + mark2 MO
NF10.5 (in situ hybridization)
|
|
|
|
fig.1.d
Mamidi A et al. (2012)
|
Xla Wt + dndvl2
NF10.5 (in situ hybridization)
|
|
|
|
fig.2..f
Julier A et al. (2012)
|
Xla Wt + pou5f3.2
NF11-11.5 (in situ hybridization)
|
|
|
|
fig.2..k
Julier A et al. (2012)
|
Xla Wt + pou5f3.2
NF11-11.5 (in situ hybridization)
|
|
|
|
fig.3. f
Julier A et al. (2012)
|
Xla Wt + pou5f3.2
NF12 (in situ hybridization)
|
|
|
|
fig.5.b
Das S and Chang C (2012)
|
Xla Wt + smurf1
NF10.5 (in situ hybridization)
|
|
|
|
fig.5.b
Das S and Chang C (2012)
|
Xla Wt + smurf1 + smurf2
NF10.5 (in situ hybridization)
|
|
|